Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	1. Occurrence of causally related SAEs throughout the study duration following vaccination <br/ >2. Ratio of GMTs <br/ >of anti-S IgG antibodiesTimepoint: 1. Throughout the study duration following vaccination <br/ >2. 28 days after the second <br/ >vaccination	1. Occurrence of causally related SAEs throughout the study duration following vaccination <br/ >2. Ratio of GMTs <br/ >of anti-S IgG antibodiesTimepoint: 1. Throughout the study duration following vaccination <br/ >2. 28 days after the second <br/ >vaccination
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Oct. 26, 2020, 8:29 a.m.	oms	1. Occurrence of causally related SAEs throughout the study duration following vaccination <br/ >2. Ratio of GMTs <br/ >of anti-S IgG antibodiesTimepoint: 1. Throughout the study duration following vaccination <br/ >2. 28 days after the second <br/ >vaccination	1. Occurrence of causally related SAEs throughout the study duration following vaccination <br/ >2. Ratio of GMTs <br/ >of anti-S IgG antibodiesTimepoint: 1. Throughout the study duration following vaccination <br/ >2. 28 days after the second <br/ >vaccination